Foresite Capital Management IV as of March 31, 2020
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 11 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics (CYTK) | 31.6 | $26M | 2.2M | 11.79 | |
| Myokardia | 17.8 | $14M | 307k | 46.88 | |
| Fulcrum Therapeutics (FULC) | 14.7 | $12M | 999k | 11.94 | |
| Insmed (INSM) | 13.4 | $11M | 678k | 16.03 | |
| Biohaven Pharmaceutical Holding | 6.6 | $5.3M | 156k | 34.03 | |
| Voyager Therapeutics (VYGR) | 5.8 | $4.7M | 517k | 9.15 | |
| Aerie Pharmaceuticals | 3.8 | $3.1M | 228k | 13.50 | |
| Bluebird Bio (BLUE) | 2.8 | $2.3M | 50k | 45.96 | |
| Kiniksa Pharmaceuticals | 1.2 | $1.0M | 65k | 15.48 | |
| Kura Oncology (KURA) | 1.1 | $925k | 93k | 9.95 | |
| Uniqure Nv (QURE) | 1.1 | $905k | 19k | 47.43 |
